Literature DB >> 17693458

Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS).

Leonie Prasad1, Virginie Masserey Spicher, Marcel Zwahlen, Martin Rickenbach, Beat Helbling, Francesco Negro.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17693458     DOI： 10.1093/ije/dym096

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN： 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  20 in total

Review 1.  Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.

Authors:  Filippo Ansaldi; Andrea Orsi; Laura Sticchi; Bianca Bruzzone; Giancarlo Icardi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

2.  Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.

Authors:  Ewa Terczyńska-Dyla; Stephanie Bibert; Francois H T Duong; Ilona Krol; Sanne Jørgensen; Emilie Collinet; Zoltán Kutalik; Vincent Aubert; Andreas Cerny; Laurent Kaiser; Raffaele Malinverni; Alessandra Mangia; Darius Moradpour; Beat Müllhaupt; Francesco Negro; Rosanna Santoro; David Semela; Nasser Semmo; Markus H Heim; Pierre-Yves Bochud; Rune Hartmann
Journal:  Nat Commun       Date:  2014-12-23       Impact factor: 14.919

3.  Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.

Authors:  Etienne Patin; Zoltán Kutalik; Julien Guergnon; Stéphanie Bibert; Bertrand Nalpas; Emmanuelle Jouanguy; Mona Munteanu; Laurence Bousquet; Laurent Argiro; Philippe Halfon; Anne Boland; Beat Müllhaupt; David Semela; Jean-François Dufour; Markus H Heim; Darius Moradpour; Andreas Cerny; Raffaele Malinverni; Hans Hirsch; Gladys Martinetti; Vijayaprakash Suppiah; Graeme Stewart; David R Booth; Jacob George; Jean-Laurent Casanova; Christian Bréchot; Charles M Rice; Andrew H Talal; Ira M Jacobson; Marc Bourlière; Ioannis Theodorou; Thierry Poynard; Francesco Negro; Stanislas Pol; Pierre-Yves Bochud; Laurent Abel
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

4.  Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups.

Authors:  Annunziata Faustini; Paola Colais; Emanuele Fabrizi; Anna Maria Bargagli; Marina Davoli; Domenico Di Lallo; Anteo Di Napoli; Patrizio Pezzotti; Chiara Sorge; Rita Grillo; Carla Maresca; Olga Recchia; Carlo A Perucci
Journal:  BMC Infect Dis       Date:  2010-04-19       Impact factor: 3.090

Review 5.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

6.  Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting.

Authors:  André Seidenberg; Thomas Rosemann; Oliver Senn
Journal:  BMC Infect Dis       Date:  2013-01-08       Impact factor: 3.090

7.  Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B.

Authors:  Shiying Li; Peng Hu; Qin-Qin Zhang; Ying-Hong Liu; Huai-Dong Hu; Da-Zhi Zhang; Hong Ren
Journal:  Hepat Mon       Date:  2011-03       Impact factor: 0.660

8.  Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development.

Authors:  Christian M Lange; Daiki Miki; Hidenori Ochi; Hans-Dieter Nischalke; Jörg Bojunga; Stéphanie Bibert; Kenichi Morikawa; Jérôme Gouttenoire; Andreas Cerny; Jean-François Dufour; Meri Gorgievski-Hrisoho; Markus H Heim; Raffaele Malinverni; Beat Müllhaupt; Francesco Negro; David Semela; Zoltan Kutalik; Tobias Müller; Ulrich Spengler; Thomas Berg; Kazuaki Chayama; Darius Moradpour; Pierre-Yves Bochud
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

9.  IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.

Authors:  Stéphanie Bibert; Thierry Roger; Thierry Calandra; Murielle Bochud; Andreas Cerny; Nasser Semmo; François H T Duong; Tilman Gerlach; Raffaele Malinverni; Darius Moradpour; Francesco Negro; Beat Müllhaupt; Pierre-Yves Bochud
Journal:  J Exp Med       Date:  2013-05-27       Impact factor: 14.307

10.  Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients.

Authors:  Thomas Kuntzen; Joerg Timm; Andrew Berical; Niall Lennon; Aaron M Berlin; Sarah K Young; Bongshin Lee; David Heckerman; Jonathan Carlson; Laura L Reyor; Marianna Kleyman; Cory M McMahon; Christopher Birch; Julian Schulze Zur Wiesch; Timothy Ledlie; Michael Koehrsen; Chinnappa Kodira; Andrew D Roberts; Georg M Lauer; Hugo R Rosen; Florian Bihl; Andreas Cerny; Ulrich Spengler; Zhimin Liu; Arthur Y Kim; Yanming Xing; Arne Schneidewind; Margaret A Madey; Jaquelyn F Fleckenstein; Vicki M Park; James E Galagan; Chad Nusbaum; Bruce D Walker; Gerond V Lake-Bakaar; Eric S Daar; Ira M Jacobson; Edward D Gomperts; Brian R Edlin; Sharyne M Donfield; Raymond T Chung; Andrew H Talal; Tony Marion; Bruce W Birren; Matthew R Henn; Todd M Allen
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.